company background image
GLAXOSMITH logo

GlaxoSmithKline Consumer Nigeria NGSE:GLAXOSMITH Stock Report

Last Price

₦17.00

Market Cap

₦20.3b

7D

0%

1Y

165.6%

Updated

09 Feb, 2024

Data

Company Financials

GlaxoSmithKline Consumer Nigeria Plc

NGSE:GLAXOSMITH Stock Report

Market Cap: ₦20.3b

GLAXOSMITH Stock Overview

GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes of consumer healthcare and pharmaceutical products in Nigeria, Africa, the Middle East, the Americas, the Asia Pacific, and Europe.

GLAXOSMITH fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends3/6

GlaxoSmithKline Consumer Nigeria Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GlaxoSmithKline Consumer Nigeria
Historical stock prices
Current Share Price₦17.00
52 Week High₦17.05
52 Week Low₦6.00
Beta0.15
1 Month Change1.19%
3 Month Change5.92%
1 Year Change165.63%
3 Year Change144.60%
5 Year Change41.67%
Change since IPO290.63%

Recent News & Updates

Recent updates

Shareholder Returns

GLAXOSMITHNG PharmaceuticalsNG Market
7D0%0.1%-3.9%
1Y165.6%13.2%120.5%

Return vs Industry: GLAXOSMITH exceeded the NG Pharmaceuticals industry which returned 17.5% over the past year.

Return vs Market: GLAXOSMITH exceeded the NG Market which returned 108.1% over the past year.

Price Volatility

Is GLAXOSMITH's price volatile compared to industry and market?
GLAXOSMITH volatility
GLAXOSMITH Average Weekly Movement2.0%
Pharmaceuticals Industry Average Movement4.2%
Market Average Movement8.2%
10% most volatile stocks in NG Market11.8%
10% least volatile stocks in NG Market2.9%

Stable Share Price: GLAXOSMITH's share price has been volatile over the past 3 months.

Volatility Over Time: GLAXOSMITH's weekly volatility has decreased from 7% to 2% over the past year.

About the Company

FoundedEmployeesCEOWebsite
197151Olakunle Oyelanawww.gsk.com/ng

GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes of consumer healthcare and pharmaceutical products in Nigeria, Africa, the Middle East, the Americas, the Asia Pacific, and Europe. It operates through two segments, Consumer Healthcare and Pharmaceuticals. The Consumer Healthcare segment offers oral care, over the counter (OTC) medicines, and nutritional healthcare products.

GlaxoSmithKline Consumer Nigeria Plc Fundamentals Summary

How do GlaxoSmithKline Consumer Nigeria's earnings and revenue compare to its market cap?
GLAXOSMITH fundamental statistics
Market cap₦20.33b
Earnings (TTM)₦735.69m
Revenue (TTM)₦15.85b

27.6x

P/E Ratio

1.3x

P/S Ratio

Is GLAXOSMITH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GLAXOSMITH income statement (TTM)
Revenue₦15.85b
Cost of Revenue₦10.62b
Gross Profit₦5.23b
Other Expenses₦4.49b
Earnings₦735.69m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.62
Gross Margin33.00%
Net Profit Margin4.64%
Debt/Equity Ratio0%

How did GLAXOSMITH perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

89%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.